Oncolytics Biotech
(NASDAQ) ONCY
Oncolytics Biotech Financials at a Glance
Market Cap
$80.79M
Revenue (TTM)
$0.00
Net Income (TTM)
$35.27M
EPS (TTM)
$-0.28
P/E Ratio
-2.86
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.86
Volume
5,905
Open
$0.83
Price
$0.86
Volume
5,905
Open
$0.83
Previous Close
$0.86
Daily Range
$0.83 - $0.86
52-Week Range
$0.33 - $1.51
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.86
Volume
5,905
Open
$0.83
Previous Close
$0.86
Daily Range
$0.83 - $0.86
52-Week Range
$0.33 - $1.51
ONCY News
A New Cancer-Killing Virus
This Week in Biotech
ONCY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oncolytics Biotech
Industry
Biotechnology
Sector
Health CareEmployees
28
CEO
Jared Kelly
Website
www.oncolyticsbiotech.comHeadquarters
Calgary, AB T2R 0C5, CA
ONCY Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-746%
Return on Capital
-24%
Return on Assets
-5%
Earnings Yield
-34.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$80.79M
Shares Outstanding
100.36M
Volume
5.91K
Short Interest
0.00%
Avg. Volume
1.35M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$28.73M
EBITDA
$28.73M
Operating Cash Flow
$20.11M
Capital Expenditure
$0.00
Free Cash Flow
$20.11M
Cash & ST Invst.
$5.20M
Total Debt
$563.00K
Oncolytics Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$80.79M
N/A
Market Cap/Employee
$2.89M
N/A
Employees
28
N/A
Net Income
$14.40M
-50.9%
EBITDA
$14.56M
-48.7%
Quarterly Fundamentals
Net Cash
$4.64M
-68.8%
Accounts Receivable
$573.00K
+742.6%
Inventory
$0.00
N/A
Long Term Debt
$370.00K
-53.0%
Short Term Debt
$193.00K
-30.3%
Return on Assets
-4.65%
N/A
Return on Invested Capital
-23.62%
N/A
Free Cash Flow
$6.66M
-36.9%
Operating Cash Flow
$6.65M
-37.6%